Technology, Obesity Treatment Highlight Patient-Centered Diabetes Care 2016
With the news that Medicare will soon pay for diabetes prevention, the 2016 edition of Patient-Centered Diabetes Care, presented by The American Journal of Managed Care, offered up-to-the-minute news on how technology will change the prevention and clinical care models, why ending stigma is key to treating obesity, and what’s ahead in insulin therapy.
FOR IMMEDIATE RELEASEAPRIL 11, 2016
TEANECK, N.J.—How will technology help Medicare make good on its promise to pay for diabetes prevention? Why is stigma among doctors still a hurdle to obesity treatment, nearly three years after the American Medical Association declared obesity a disease? And how are retail clinics filling gaps in diabetes care?
These were just some of the questions covered during the fourth meeting of
Conference Chair Robert A. Gabbay, MD, PhD, FACP, chief medical officer and senior vice president of
“If one adds up all the money spent on things that don’t work,” Gabbay said, “We’d probably have money for the things that do work.”
Technology is changing the clinical care model and may change the way we answer questions in diabetes, according to
Right now, he said, the healthcare system is not doing a very good job of deploying resources in diabetes care. “We really need to take advantage of what’s available to us, to exploit all these data sources.”
Reisman evoked themes offered just a week earlier by a fellow cardiologist, FDA Commissioner
In the short term, technology will play a role in Medicare’s ability to bring the National Diabetes Program (NDPP) to the millions of potential beneficiaries, said Mike Payne, chief commercial officer of Omada Health, who was part of a session on the role of technology in diabetes care. Omada is ready to deliver the NDPP now that the Centers for Medicare & Medicaid Services (CMS) is committed to paying for the program. “The fact that CMS has taken this step is really encouraging,” he said.
But when it comes to treatment for those who already have diabetes,
Other sessions covered clinical and healthcare delivery topics, such as new options in insulin treatment, cardiovascular risk for those with diabetes, and the role of retail clinics in meeting the needs of those who lack insurance or cannot make appointments during the day.
“From clinical studies that were less than a week old to game-changing news in reimbursement, our speakers were unmatched in their knowledge of what is happening in diabetes care,” said Brian Haug, president of Pharmacy and Managed Markets and publisher of The American Journal of Managed Care. “We continue to set the standard in our ability to bring together stakeholders from across healthcare and to offer the most current information in the field.”
Full coverage of the meeting will appear in a special issue of Evidence-Based Diabetes Management later this year.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Assessing the Rising Prevalence of Early-Onset Type 2 Diabetes in the US
September 16th 2025
- Workforce Innovation Reduces Medicaid Costs in Chronic Care
September 11th 2025